Colorectal Cancer

Researchers are gaining new insight into long-term aspirin use for the prevention of colorectal cancer.

Anjee Davis, president, Fight Colorectal Cancer, discusses the future of research in colorectal cancer and the importance of research advocates.

Does drinking a lot of coffee reduce colon cancer recurrence risk? Possibly.

Colorectal cancer is the third leading cause of cancer-related deaths in the United States when men and women are considered separately, and the second leading cause when both sexes are combined.

I can remember every waking moment feeling like an incredible dream for months afterward. During those moments I was so much in love I couldn't imagine or believe that anything could bring more happiness. I wanted that feeling to last into our rocking chair days.

'Happy birthday' messages greeted me from around the globe. Because of cancer, my life has been touched by friends far and wide, around the country and across the ocean.

It doesn't get any easier to say goodbye to a friend and it brings close the reality that though we are living better, and longer with advanced cancer, that there is still no cure.

Though having a high body mass index (BMI) is associated with a higher risk for colorectal cancer, patients who are thinner may not do as well after treatment for metastatic colorectal cancer (mCRC).

The hotspots were identified in the lower Mississippi Delta, west central region of Appalachia and northeastern North Carolina/southeastern Virginia.

Chris4Life Colon Cancer Foundation and Myriad Genetics have announced an educational campaign to help individuals learn more about the history of cancer in their family, which may aid them in the prevention or treatment of future cancers.

Our cancer story began on a perfect August night.

Patients with heavily pretreated colorectal cancer who harbored genetic defects in DNA mismatch repair (MMR) experienced high response rates when treated with the PD-1 inhibitor Keytruda (pembrolizumab) in a recent study.

After receiving approvals for advanced gastric cancer and metastatic non–small cell lung cancer in 2014, Cyramza (ramucirumab) gained yet another approval in April 2015.

The FDA has approved second-line Cyramza in combination with FOLFIRI chemotherapy regimen as a treatment for patients with metastatic colorectal cancer following progression on a first-line Avastin-containing regimen.

A recent study joins a body of evidence suggesting that long-term, regular aspirin use is associated with a reduced risk for cancer, with the most dramatic reduction being seen in colorectal cancer incidence.

ON THE VERGE OF UNDERSTANDING: That's what the cover of this issue of CURE declares, and that's exactly where science is when it comes to figuring out colorectal cancer today.

Caring for a loved one means being there through treatment, side effects and worry—but also finding time for yourself.

The diagnosis of a hereditary syndrome that can lead to colorectal cancer—such as Lynch syndrome or familial adenomatous polyposis (FAP)—can be permanently life-changing, counselors and patients agree.